India to New Zealand: Pomalidomide Export Trade Route
India has recorded 26 verified shipments of Pomalidomide exported to New Zealand, representing a combined trade value of $31.6K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $1.2K USD. The leading Indian exporter is VISHAKHA IMPEX, which accounts for 74% of total export value with 19 shipments worth $23.3K USD. On the buying side, ALQUIMIA LIMITED (COOKST PHARMACY) is the largest importer in New Zealand with $15.3K USD in purchases. The top 3 suppliers — VISHAKHA IMPEX, VISHAKHA IMPEX , SPECIALITY MEDICINES PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to New Zealand Pomalidomide corridor is one of India's established pharmaceutical export routes, with 26 shipments documented worth a combined $31.6K USD. The route is dominated by VISHAKHA IMPEX, which alone accounts for roughly 74% of all export value, reflecting the consolidated nature of India's pomalidomide manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $1.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with pomalidomide's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 22.8%, placing it at rank #13 among India's top pomalidomide export destinations globally.
On the import side, key buyers of Indian pomalidomide in New Zealand include ALQUIMIA LIMITED (COOKST PHARMACY), ALQUIMIA LIMITED (COOKST PHARMACY) , ALQUIMIA LIMITED and 3 others. ALQUIMIA LIMITED (COOKST PHARMACY) is the single largest importer with 14 shipments valued at $15.3K USD.
Route Characteristics
- Average transit30 days
- Peak seasonQ3
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#13
- Annual growth+22.8%
- Demand growth+19.3%
- Regulatory ease80/100
Top 10 Indian Pomalidomide Exporters to New Zealand
Showing top 10 of 3 Indian suppliers exporting Pomalidomide to New Zealand, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VISHAKHA IMPEX Avg $1.2K per shipment | 19 | $23.3K | 73.6% |
| 2 | VISHAKHA IMPEX Avg $1.4K per shipment | 6 | $8.1K | 25.6% |
| 3 | SPECIALITY MEDICINES PRIVATE LIMITED Avg $238 per shipment | 1 | $238 | 0.8% |
This table shows the top 10 of 3 Indian companies exporting pomalidomide to New Zealand, ranked by total trade value. The listed exporters are: VISHAKHA IMPEX, VISHAKHA IMPEX , SPECIALITY MEDICINES PRIVATE LIMITED. VISHAKHA IMPEX is the dominant supplier with 19 shipments worth $23.3K USD, giving it a 74% market share.
Top 10 Pomalidomide Importers in New Zealand
Showing top 10 of 6 known buyers in New Zealand receiving Pomalidomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian pomalidomide in New Zealand include ALQUIMIA LIMITED (COOKST PHARMACY), ALQUIMIA LIMITED (COOKST PHARMACY) , ALQUIMIA LIMITED, ALQUIMIA LIMITED COOKST PHARMACY, ALQUIMIA LTD, among 6 total buyers. The largest importer is ALQUIMIA LIMITED (COOKST PHARMACY), accounting for $15.3K USD across 14 shipments — representing 48% of all pomalidomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ALQUIMIA LIMITED (COOKST PHARMACY) | 14 | $15.3K | 48.5% |
| 2 | ALQUIMIA LIMITED (COOKST PHARMACY) | 6 | $8.1K | 25.6% |
| 3 | ALQUIMIA LIMITED | 2 | $3.2K | 10.1% |
| 4 | ALQUIMIA LIMITED COOKST PHARMACY | 2 | $3.1K | 9.9% |
| 5 | ALQUIMIA LTD | 1 | $1.6K | 5.0% |
| 6 | PAUL THOMAS | 1 | $238 | 0.8% |
Top 10 Pomalidomide Formulations Imported by New Zealand
Showing top 10 of 17 product formulations shipped on the India to New Zealand Pomalidomide route, ranked by trade value
New Zealand imports a wide range of pomalidomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — POMALID 4MG CAPSULES POMALIDOMIDE 4MG — accounts for $4.8K USD across 3 shipments. There are 17 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | POMALID 4MG CAPSULES POMALIDOMIDE 4MG | 3 | $4.8K | 15.1% |
| 2 | POMALID 4MG CAPSULES (POMALIDOMIDE 4MG) | 4 | $3.5K | 11.1% |
| 3 | POMALID 4MG CAPSULES (POMALIDOMIDE 4MG )(21'S)NOS | 3 | $3.5K | 11.1% |
| 4 | POMALID 4MG CAPSULES(POMALIDOMIDE 4MG)(2 | 2 | $3.2K | 10.0% |
| 5 | POMALID 4MG CAPSULES(POMALIDOMIDE 4MG) | 1 | $1.8K | 5.7% |
| 6 | POMALID 4MG CAPSULES (POMALIDOMIDE 4MG)(21'S) | 1 | $1.6K | 5.1% |
| 7 | POMALID 4MG CAPSULES (POMALIDOMIDE 4MG)(21'S) | 1 | $1.6K | 5.1% |
| 8 | POMALID 4MG CAPSULES (POMALIDOMIDE 4 MG) | 1 | $1.6K | 5.0% |
| 9 | POMALID 4 MG CAPSULES POMALIDOMIDE 4 MG | 1 | $1.6K | 5.0% |
| 10 | POMALID 4MG CAPSULES POMALIDOMIDE 4MG21'S | 1 | $1.6K | 5.0% |
Showing top 10 of 17 Pomalidomide formulations imported by New Zealand on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 77%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 15 shipments. Transit time averages 30 days by sea.
Market Dynamics
India's pomalidomide exports to New Zealand are driven primarily by a handful of large-scale manufacturers. VISHAKHA IMPEX with 19 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in New Zealand benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — VISHAKHA IMPEX, VISHAKHA IMPEX , SPECIALITY MEDICINES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $1.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pomalid 4mg capsules (pomalidomide 4mg) and pomalid 4mg capsules (pomalidomide 4mg )(21's)nos, suggesting that buyers in New Zealand tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ALQUIMIA LIMITED (COOKST PHARMACY) is the largest importer with 14 shipments worth $15.3K USD — representing 48% of all pomalidomide imports from India on this route. A total of 6 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $31.6K
- Avg. Shipment
- $1.2K
- Suppliers
- 3
- Buyers
- 6
- Transit (Sea)
- ~30 days
- Annual Growth
- +22.8%
Related Analysis
Other Pomalidomide Routes
Unlock the Full India to New Zealand Pomalidomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 26 shipments on this route.
Frequently Asked Questions — India to New Zealand Pomalidomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Pomalidomide to New Zealand?
The leading Indian exporters of Pomalidomide to New Zealand are VISHAKHA IMPEX, VISHAKHA IMPEX , SPECIALITY MEDICINES PRIVATE LIMITED. VISHAKHA IMPEX holds the largest market share at approximately 74% of total trade value on this route.
Q What is the total value of Pomalidomide exports from India to New Zealand?
India exports Pomalidomide to New Zealand worth approximately $31.6K USD across 26 recorded shipments. The average value per shipment is $1.2K USD.
Q Which ports does India use to ship Pomalidomide to New Zealand?
The most active port of origin is SAHAR AIR with 15 shipments. Indian exporters primarily use sea freight for this route, with 77% of shipments going by sea and 24% by air.
Q How long does shipping take from India to New Zealand for Pomalidomide?
The average transit time for Pomalidomide shipments from India to New Zealand is approximately 30 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to New Zealand Pomalidomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 22.8% with demand growth tracking at 19.3%. The route is ranked #13 among India's top Pomalidomide export destinations globally.
Q How many suppliers are active on the India to New Zealand Pomalidomide route?
There are currently 3 active Indian suppliers exporting Pomalidomide to New Zealand. The market is moderately concentrated with VISHAKHA IMPEX accounting for 74% of total shipment value.
Q Who are the main importers of Pomalidomide from India in New Zealand?
The leading importers of Indian Pomalidomide in New Zealand include ALQUIMIA LIMITED (COOKST PHARMACY), ALQUIMIA LIMITED (COOKST PHARMACY) , ALQUIMIA LIMITED, ALQUIMIA LIMITED COOKST PHARMACY, ALQUIMIA LTD. ALQUIMIA LIMITED (COOKST PHARMACY) is the largest buyer with 14 shipments worth $15.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to New Zealand export trade corridor identified from Indian Customs (DGFT) records for Pomalidomide.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 6 importers in New Zealand matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 26 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
26 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists